# FDA Inspection 1242170 - Orthobone, Inc. - June 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/orthobone-inc/72363771-7987-4e8b-935c-b62dfb61a486
Source feed: FDA_Inspections

> FDA Inspection 1242170 for Orthobone, Inc. on June 18, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242170
- Company Name: Orthobone, Inc.
- Inspection Date: 2024-06-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1115375 - 2020-01-15](https://www.keypedia.com/records/fda_inspections/orthobone-inc/1b77f089-444b-4f28-bb17-88e34d1d7175)
- [FDA Inspection 1065410 - 2018-08-16](https://www.keypedia.com/records/fda_inspections/orthobone-inc/19afd4d6-5950-428b-baba-355f55be93a6)
- [FDA Inspection 970058 - 2016-05-04](https://www.keypedia.com/records/fda_inspections/orthobone-inc/13bdb51b-5d39-4360-9edb-b394672f0fdc)
- [FDA Inspection 770808 - 2012-03-02](https://www.keypedia.com/records/fda_inspections/orthobone-inc/c672cd56-d06e-4975-8822-ed37ec63d8a5)

Company: https://www.keypedia.com/companies/orthobone-inc/66612f36-c0ae-4f86-87a5-5d4bef71caa6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d